Survival outcomes after neoadjuvant letrozole and palbociclib versus third generation chemotherapy for patients with high-risk oestrogen receptor-positive HER2-negative breast cancer
Titel:
Survival outcomes after neoadjuvant letrozole and palbociclib versus third generation chemotherapy for patients with high-risk oestrogen receptor-positive HER2-negative breast cancer
Auteur:
Delaloge, Suzette Dureau, Sylvain D'Hondt, Véronique Desmoulins, Isabelle Heudel, Pierre-Etienne Duhoux, Francois P. Levy, Christelle Lerebours, Florence Mouret-Reynier, Marie A. Dalenc, Florence Frenel, Jean-Sébastien Jouannaud, Christelle Venat-Bouvet, Laurence Nguyen, Suzanne Callens, Cécile Gentien, David Rapinat, Audrey Manduzio, Helene Vincent-Salomon, Anne Lemonnier, Jérôme Cottu, Paul